Insights
PR & IR
IR Notice
IR Notice
PR
News
Blog
IR
Disclosure
Announcement
Title
Content
[IR Event] Company Report: Korea's Leading CRO Enters Global Top 50 — Backlog Translates into Profit, While Headquarters Value Provides Strong Downside Support
2026-11-16
[IR Event] NDR
2026-10-28
[IR Event] NDR
2026-10-20
[IR Letter] 2026.Q2
2026-09-23
[IR Event] NDR
2026-09-15
[IR Event] Company Report: CROs Set to Benefit as Eli Lilly & Roche Deploy KRW 1.4T in Korea Alongside National Growth Fund Inflows
2026-09-02
1
2
3
4